These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8139721)

  • 21. Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.
    Luk GD
    Schweiz Med Wochenschr; 1996 May; 126(19):801-12. PubMed ID: 8693304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Will gene testing cut risk of familial colorectal cancer?
    Lucassen A; Houlston R
    Practitioner; 1998 Apr; 242(1585):306-10, 314. PubMed ID: 10492991
    [No Abstract]   [Full Text] [Related]  

  • 23. [Molecular genetics in colorectal cancer].
    Salamanca-Gómez F
    Gac Med Mex; 1996; 132(4):441-2. PubMed ID: 8964386
    [No Abstract]   [Full Text] [Related]  

  • 24. Hereditary colorectal cancer syndromes.
    Strate LL; Syngal S
    Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biological bases of the colorectal adenoma-carcinoma sequence].
    Stella S; Bruzzese A; Chiarini S
    G Chir; 1996 Oct; 17(10):473-6. PubMed ID: 9044597
    [No Abstract]   [Full Text] [Related]  

  • 26. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
    Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):863-70. PubMed ID: 15824157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonality of dysplastic epithelium in colorectal adenomas from familial adenomatous polyposis patients.
    Bjerknes M; Cheng H; Kim H; Schnitzler M; Gallinger S
    Cancer Res; 1997 Feb; 57(3):355-61. PubMed ID: 9012454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
    Strul H; Arber N
    Isr Med Assoc J; 2000 Sep; 2(9):695-702. PubMed ID: 11062772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
    Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is it possible to eradicate inherited polyposis coli in colorectal cancer by using genetic diagnosis].
    de la Chapelle A
    Duodecim; 1996; 112(15):1365-8. PubMed ID: 10596118
    [No Abstract]   [Full Text] [Related]  

  • 31. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.
    Sangha S; Yao M; Wolfe MM
    Postgrad Med J; 2005 Apr; 81(954):223-7. PubMed ID: 15811884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mutational studies of adenomatous polyposis coli gene in carcinomas from patients with hereditary non-polyposis colorectal cancers].
    Huang J; Jin SH; Zhang SZ; Zheng S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):196-9. PubMed ID: 12778442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can resistant starch and/or aspirin prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 Study.
    Mathers JC; Mickleburgh I; Chapman PC; Bishop DT; Burn J;
    Proc Nutr Soc; 2003 Feb; 62(1):51-7. PubMed ID: 12740057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic diagnosis of colorectal cancer].
    Itoh F; Imai K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):9-14. PubMed ID: 8727369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoprevention of colorectal cancer.
    Jänne PA; Mayer RJ
    N Engl J Med; 2000 Jun; 342(26):1960-8. PubMed ID: 10874065
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
    Florent C; Meary N
    Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoprevention of colorectal carcinogenesis.
    Umar A; Viner JL; Richmond E; Anderson WF; Hawk ET
    Int J Clin Oncol; 2002 Feb; 7(1):2-26. PubMed ID: 11942045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical research of familial adenomatous polyposis: current status and issues].
    Iida M
    Fukuoka Igaku Zasshi; 2009 Dec; 100(12):349-59. PubMed ID: 20384205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.